Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00665678Phase 4Terminated
Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing paroxetine with placebo (2 arms). Primary endpoint: Clinician-Administered PTSD Scale at 3 months. Started Apr 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00665678.